MTBVAC
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
MTBVAC is a candidate vaccine against tuberculosis in humans currently in clinical trials. It is based on a genetically modified form of the Mycobacterium tuberculosis pathogen isolated from humans. Unlike the BCG vaccine, MTBVAC contains all the antigens present in the strains that infect humans.
MTBVAC is a candidate vaccine against tuberculosis in humans currently in clinical trials. It is based on a genetically modified form of the Mycobacterium tuberculosis pathogen isolated from humans. Unlike the BCG vaccine, MTBVAC contains all the antigens present in the strains that infect humans.
References
Text derived from https://en.wikipedia.org/w/index.php?oldid=1359877130 under CC BY-SA 4.0; modifications have been made.